Alzheimer's Disease Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Alzheimer's disease (AD) patients:

• People who have been diagnosed with probable Alzheimer's disease, confirmed through recognised clinical and biological criteria
• People with mild to moderate Alzheimer's disease, based on a standard memory and thinking test score of 15 or above (out of 30)
• People who are fluent enough in French to complete study questionnaires
• People who agree to attend medical check-ups at the start of the study, and again at 12 and 24 months
• People who are enrolled in the French social security system
• People who give written consent to participate

Caregivers:

• People who assist an AD patient with daily activities for at least 6 hours per week over the past 6 months, where that patient has also agreed to take part in the study
• People aged 18 or older
• People who are fluent enough in French to complete study questionnaires
• People who agree to regularly fill in questionnaires about their own health or the AD patient's health, either during visits, online, or by post
• People who are enrolled in the French social security system
• People who give written consent to participate

First-degree relatives (such as parents, children, or siblings of an AD patient):

• People who are a first-degree relative of an AD patient who has also agreed to take part in the study
• People aged 18 or older
• People who are fluent enough in French to complete study questionnaires
• People who agree to attend medical check-ups at the start of the study, and again at 12 and 24 months
• People who agree to regularly fill in questionnaires about their own health, either online or by post
• People who are enrolled in the French social security system
• People who give written consent to participate

Group structure requirement:

• The study requires a family group of 2 to 5 people: either 1 AD patient and 1 first-degree relative who also acts as their caregiver, OR 1 AD patient, 1 caregiver (who does not need to be a relative), and between 1 and 3 first-degree relatives of the patient

Who may not be able to join:

AD patients:

• People who have another brain condition in addition to Alzheimer's disease
• People whose Alzheimer's disease is caused by a directly inherited (autosomal dominant) genetic form of the condition
• People who are under a legal protection arrangement, such as guardianship or a similar measure
• People who are currently living in a care home or institution
• People whose life expectancy is less than 2 years

Caregivers:

• People who are under a legal protection arrangement, such as guardianship or a similar measure
• People who have been diagnosed with a serious condition affecting memory and thinking (major neurocognitive disorder)

First-degree relatives:

• People whose family member has an inherited (autosomal dominant) form of dementia
• People who carry a known gene mutation linked to inherited dementia
• People who are under a legal protection arrangement, such as guardianship or a similar measure
• People who have been diagnosed with a serious condition affecting memory and thinking (major neurocognitive disorder)

Important: Always verify eligibility with the trial site directly before applying.